Cargando…

Antiepileptic Drugs.

The thoroughly revised, updated Fifth Edition of this classic is the most comprehensive, current, and authoritative reference on all anticonvulsants available today. This edition features detailed profiles of newer drugs--including levetiracetam, oxcarbazepine, tiagabine, topiramate, and zonisamide-...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Levy, René H.
Otros Autores: Mattson, Richard H., Meldrum, Brian S.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Philadelphia : Wolters Kluwer Health, 2002.
Edición:5th ed.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn908076220
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 150509s2002 pau o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d YDXCP  |d OCLCQ  |d ZCU  |d MERUC  |d ICG  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d DKC  |d AU@  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 923528994  |a 929151885 
020 |a 9781469877266 
020 |a 1469877260 
029 1 |a DEBBG  |b BV044074271 
035 |a (OCoLC)908076220  |z (OCoLC)923528994  |z (OCoLC)929151885 
050 4 |a RC374 .C48 A58 2002 
082 0 4 |a 616.8  |a 616.853061 
049 |a UAMI 
100 1 |a Levy, René H. 
245 1 0 |a Antiepileptic Drugs. 
250 |a 5th ed. 
260 |a Philadelphia :  |b Wolters Kluwer Health,  |c 2002. 
300 |a 1 online resource (987 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a Antiepileptic drugs; contents; contributing authors; preface; section i general principles; 1 principles of antiepileptic drug action; 2 neurophysiologic effects of antiepileptic drugs; 3 discovery and preclinical development of antiepileptic drugs; 4 new antiepileptic drug development: medical perspective; 5 clinical development of antiepileptic drugs: industry perspective; 6 the development of antiepileptic drugs: regulatory perspective; 7 antiepileptic drug monotherapy in adults: selection and use in new-onset epilepsy; 8 combination therapy and drug interactions. 
505 8 |a 9 laboratory monitoring of antiepileptic drugs 10 safety monitoring of antiepileptic drugs; 11 use of antiepileptic drugs in children; 12 antiepileptic drug use in women; 13 epilepsy in the elderly; 14 treatment of status epilepticus; 15 prevention of epileptogenesis; section ii benzodiazepines; 16 mechanisms of action; 17 chemistry, biotransformation, and pharmacokinetics; 18 clinical efficacy and use in epilepsy; 19 adverse effects; section iii carbamazepine; 20 mechanisms of action; 21 chemistry, biotransformation, and pharmacokinetics; 22 interactions with other drugs. 
505 8 |a 23 clinical efficacy and use in epilepsy24 clinical efficacy and use in other neurologic disorders; 25 clinical efficacy and use in psychiatric disorders; 26 adverse effects; section iv felbamate; 27 felbamate; section v gabapentin; 28 mechanisms of action; 29 chemistry, biotransformation, pharmacokinetics, and interactions; 30 clinical use; 31 clinical efficacy and use in other neurological disorders; 32 clinical efficacy and use in psychiatric disorders; 33 adverse effects; section vi lamotrigine; 34 mechanisms of action; 35 chemistry, biotransformation, and pharmacokinetics. 
505 8 |a 36 interaction with other drugs37 clinical efficacy and use in epilepsy; 38 efficacy and use in psychiatric disorders; 39 adverse effects; section vii i levetiracetam; 40 mechanisms of action; 41 chemistry, biotransformation, pharmacokinetics, and drug interactions; 42 clinical use; 43 adverse experiences; section viii oxcarbazepine; 44 mechanisms of action; 45 chemistry, biotransformation, and pharmacokinetics; 46 interactions with other drugs; 47 clinical efficacy and use in epilepsy; 48 clinical efficacy and use in psychiatric disorders; 49 adverse effects. 
505 8 |a Section ix phenobarbital and other barbiturates50 mechanisms of action; 51 chemistry, biotransformation, and pharmacokinetics; 52 interactions with other drugs; 53 clinical efficacy and use in epilepsy; 54 clinical efficacy and use in nonepileptic disorders; 55 adverse effects; 56 methylphenobarbital; section x phenytoin and other hydantoins; 57 mechanisms of action; 58 chemistry and biotransformation; 59 interactions with other drugs; 60 clinical efficacy and use in epilepsy; 61 clinical efficacy and use in other neurological disorders; 62 clinical efficacy and use in psychiatric disorders. 
500 |a 63 adverse effects. 
520 |a The thoroughly revised, updated Fifth Edition of this classic is the most comprehensive, current, and authoritative reference on all anticonvulsants available today. This edition features detailed profiles of newer drugs--including levetiracetam, oxcarbazepine, tiagabine, topiramate, and zonisamide--and new chapters on use of antiepileptic drugs in children and during pregnancy. Drugs are covered in alphabetical order and in an easy-to-follow format: mechanisms of action; chemistry, biotransformation, and pharmacokinetics; interactions; clinical efficacy and use; and adverse effects. Coverage. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Epilepsy  |x Chemotherapy. 
650 0 |a Anticonvulsants. 
650 2 |a Anticonvulsants 
650 6 |a Anticonvulsivants. 
650 7 |a Anticonvulsants  |2 fast 
650 7 |a Epilepsy  |x Chemotherapy  |2 fast 
700 1 |a Mattson, Richard H. 
700 1 |a Meldrum, Brian S. 
758 |i has work:  |a Antiepilptic drugs (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCYTfphkr7RMBdTMTvdp773  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Levy, René H.  |t Antiepileptic Drugs.  |d Philadelphia : Wolters Kluwer Health, ©2002  |z 9780781723213 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=2032676  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL2032676 
938 |a YBP Library Services  |b YANK  |n 11705178 
994 |a 92  |b IZTAP